YU10384A - Process for making compounds with heterocyclic diazotic kernel - Google Patents

Process for making compounds with heterocyclic diazotic kernel

Info

Publication number
YU10384A
YU10384A YU00103/84A YU10384A YU10384A YU 10384 A YU10384 A YU 10384A YU 00103/84 A YU00103/84 A YU 00103/84A YU 10384 A YU10384 A YU 10384A YU 10384 A YU10384 A YU 10384A
Authority
YU
Yugoslavia
Prior art keywords
image
diazotic
kernel
heterocyclic
compounds
Prior art date
Application number
YU00103/84A
Other languages
English (en)
Inventor
K Biziere
J P Chambon
A Hallot
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of YU10384A publication Critical patent/YU10384A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymerisation Methods In General (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
YU00103/84A 1983-01-21 1984-01-20 Process for making compounds with heterocyclic diazotic kernel YU10384A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8300954A FR2539741A1 (fr) 1983-01-21 1983-01-21 Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Publications (1)

Publication Number Publication Date
YU10384A true YU10384A (en) 1986-10-31

Family

ID=9285183

Family Applications (1)

Application Number Title Priority Date Filing Date
YU00103/84A YU10384A (en) 1983-01-21 1984-01-20 Process for making compounds with heterocyclic diazotic kernel

Country Status (30)

Country Link
US (1) US4624952A (xx)
EP (1) EP0114770B1 (xx)
JP (1) JPS59137469A (xx)
KR (1) KR910000640B1 (xx)
AT (1) ATE28453T1 (xx)
AU (1) AU563160B2 (xx)
CA (1) CA1217490A (xx)
CS (1) CS242894B2 (xx)
DD (1) DD216014A5 (xx)
DE (1) DE3464909D1 (xx)
DK (1) DK25684A (xx)
EG (1) EG16212A (xx)
ES (1) ES528921A0 (xx)
FI (1) FI79537C (xx)
FR (1) FR2539741A1 (xx)
GR (1) GR79766B (xx)
HU (1) HU191586B (xx)
IE (1) IE56569B1 (xx)
IL (1) IL70740A (xx)
MA (1) MA20007A1 (xx)
NO (1) NO159170C (xx)
NZ (1) NZ206906A (xx)
OA (1) OA07638A (xx)
PH (1) PH21060A (xx)
PL (1) PL143224B1 (xx)
PT (1) PT77966B (xx)
SG (1) SG2189G (xx)
SU (1) SU1342415A3 (xx)
YU (1) YU10384A (xx)
ZA (1) ZA84342B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
DE3517617A1 (de) * 1985-05-15 1986-11-20 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Neue pyridaziniumverbindungen, verfahren zu deren herstellung und diese enthaltende fungizide und algizide mittel
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
FR2676444B1 (fr) * 1991-05-16 1995-03-10 Sanofi Elf Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US8575167B2 (en) * 2007-02-06 2013-11-05 Takeda Pharmaceutical Company Limited Spiro compounds having stearoyl-CoA desaturase action
EP3312179B1 (en) 2015-04-29 2019-07-10 Nanjing Sanhome Pharmaceutical Co., Ltd. Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
US4302455A (en) * 1980-04-14 1981-11-24 Merck & Co., Inc. 2-(4-Aminopiperidino)pyrazines
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2511366A1 (fr) * 1981-08-11 1983-02-18 Sanofi Sa Nouveaux derives de la pyridazine, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent

Also Published As

Publication number Publication date
DE3464909D1 (en) 1987-08-27
CS42484A2 (en) 1985-08-15
FI79537B (fi) 1989-09-29
IE840102L (en) 1984-07-21
KR840007406A (ko) 1984-12-07
KR910000640B1 (ko) 1991-01-31
PH21060A (en) 1987-07-10
NO159170B (no) 1988-08-29
AU2323684A (en) 1984-07-26
EG16212A (en) 1989-06-30
ZA84342B (en) 1984-08-29
AU563160B2 (en) 1987-07-02
FI840238A0 (fi) 1984-01-20
FR2539741B1 (xx) 1985-05-17
HU191586B (en) 1987-03-30
DD216014A5 (de) 1984-11-28
OA07638A (fr) 1985-05-23
PL143224B1 (en) 1988-01-30
SG2189G (en) 1989-06-02
NO159170C (no) 1988-12-07
JPS59137469A (ja) 1984-08-07
EP0114770A3 (en) 1984-08-22
FI79537C (fi) 1990-01-10
EP0114770B1 (en) 1987-07-22
IL70740A (en) 1986-09-30
IE56569B1 (en) 1991-09-11
DK25684D0 (da) 1984-01-20
FI840238A (fi) 1984-07-22
ES8407040A1 (es) 1984-09-01
CA1217490A (en) 1987-02-03
US4624952A (en) 1986-11-25
SU1342415A3 (ru) 1987-09-30
NZ206906A (en) 1987-05-29
MA20007A1 (fr) 1984-10-01
DK25684A (da) 1984-07-22
IL70740A0 (en) 1984-04-30
CS242894B2 (en) 1986-05-15
PL245836A1 (en) 1985-07-02
PT77966A (fr) 1984-02-01
GR79766B (xx) 1984-10-31
EP0114770A2 (fr) 1984-08-01
PT77966B (fr) 1986-07-11
FR2539741A1 (fr) 1984-07-27
NO840214L (no) 1984-07-23
ATE28453T1 (de) 1987-08-15
ES528921A0 (es) 1984-09-01

Similar Documents

Publication Publication Date Title
YU10384A (en) Process for making compounds with heterocyclic diazotic kernel
FR2320300A1 (fr) Procede de preparation de chromanones-(4)
FR2326409A2 (fr) Procede de preparation d'arylamines
PT67096B (en) Process for the preparation of n-substituted bis-carbamoylsulfide compounds
BE844943A (fr) Procede de preparation de chromanones-(4)
FR2327995A1 (fr) Procede ameliore de preparation de vanadate d'ethyle
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
BE837906A (fr) Procede de preparation de n-(alpha-alcoxyethyl)-carboxamides
OA05206A (fr) Procédé de préparation de dérivés d'amines.
ZA764225B (en) Distillative purification of 2,5-dioxo-1-oxa-2-phospholanes
FR2306198A1 (fr) Procede discontinu de preparation de l'iminodiacetonitrile
IL50247A0 (en) Process for the preparation of 3-(3, 5-dichlorophenyl)-hydantoin
FR2336377A1 (fr) Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine
BE845878A (fr) Procede de preparation directe d'alpha-amino y -cetoacides n-acyles etcomposes correspondants
BE849390A (fr) Procede de preparation de la n-(3,4-dimethylphenyl)-d-ribamine
BE587137A (fr) Procédé de préparation d'amides aromatiques ortho-disubstituées.
BE845867A (fr) Procede de preparation de l'iminodiacetonitrile
BE846859R (fr) Procede de preparation d'arylamines,
IL50471A (en) Process for the preparation of n -(2'-furanidyl)-5-fluoro-uracil
PT69319A (en) Process for the preparation of n-(pyridothienopyrazol)amide antirhinoviral agents
IL47539A (en) Process for the preparation of an enzymatically active polymeric prosuct
GR61184B (en) Preparation process of anthel minthic active,basic substituted 2-carbalkoxy amino-benzimidazolyl-5(6)-phenyl-ethers and-ketones